| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 76.754 | 78.265 | 71.660 | 90.020 | 80.989 | 60.243 | 65.990 | 84.282 | 93.195 | 87.457 |
| Total Income - EUR | 77.660 | 78.315 | 71.669 | 90.086 | 81.129 | 61.964 | 82.587 | 86.682 | 93.293 | 89.623 |
| Total Expenses - EUR | 68.257 | 66.220 | 76.930 | 71.595 | 69.532 | 55.298 | 70.872 | 68.359 | 89.378 | 78.174 |
| Gross Profit/Loss - EUR | 9.403 | 12.094 | -5.261 | 18.491 | 11.597 | 6.666 | 11.715 | 18.323 | 3.915 | 11.449 |
| Net Profit/Loss - EUR | 6.980 | 11.311 | -5.978 | 17.592 | 10.786 | 6.221 | 11.233 | 17.606 | 3.122 | 9.009 |
| Employees | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 3 | 4 | 3 |
Check the financial reports for the company - Bioref Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.425 | 2.419 | 215.414 | 207.496 | 198.570 | 189.992 | 181.227 | 177.295 | 421.830 | 592.705 |
| Current Assets | 15.495 | 20.048 | 12.586 | 25.385 | 19.422 | 15.598 | 17.719 | 27.852 | 26.519 | 24.211 |
| Inventories | 566 | 614 | 724 | 414 | 386 | 240 | 299 | 370 | 312 | 447 |
| Receivables | 3.522 | 1.898 | 1.773 | 6.194 | 3.960 | 4.230 | 5.606 | 7.676 | 3.840 | 4.611 |
| Cash | 11.407 | 17.536 | 10.089 | 18.777 | 15.076 | 11.128 | 11.813 | 19.806 | 22.368 | 19.153 |
| Shareholders Funds | 8.467 | 19.691 | 2.261 | 19.811 | 30.213 | 35.862 | 46.164 | 63.902 | 66.829 | 75.465 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.583 | 5.409 | 225.811 | 213.221 | 187.796 | 169.947 | 152.712 | 141.554 | 381.817 | 541.701 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 300 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5590 - 5590" | |||||||||
| CAEN Financial Year |
5590
|
|||||||||
Comments - Bioref Srl